Cyclosporine lymphocyte maximum level

Objectives: To determine the relationship between clinical outcome, lymphocyte count (LC), and cyclosporine (CsA) lymphocyte maximum level (LTmL) in kidney transplant recipients. Materials and Methods: CsA LTmL was determined in patients with biopsy-proven graft dysfunction and in patients with norm...

Full description

Saved in:
Bibliographic Details
Main Author: Kilani, Halal E. (author)
Other Authors: Karam, Albert S. (author), Masri, Marwan A. (author), Stephan, Antoine G. (author), Mourad, Nina (author), El Ghoul, Bassam (author)
Format: article
Published: 2005
Online Access:http://hdl.handle.net/10725/10372
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://www.ectrx.org/forms/ectrxcontentshow.php?year=2005&volume=3&issue=1&supplement=0&makale_no=0&spage_number=293&content_type=FULL%20TEXT
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513486571175937
author Kilani, Halal E.
author2 Karam, Albert S.
Masri, Marwan A.
Stephan, Antoine G.
Mourad, Nina
El Ghoul, Bassam
author2_role author
author
author
author
author
author_facet Kilani, Halal E.
Karam, Albert S.
Masri, Marwan A.
Stephan, Antoine G.
Mourad, Nina
El Ghoul, Bassam
author_role author
dc.creator.none.fl_str_mv Kilani, Halal E.
Karam, Albert S.
Masri, Marwan A.
Stephan, Antoine G.
Mourad, Nina
El Ghoul, Bassam
dc.date.none.fl_str_mv 2005
2019-04-09T06:13:09Z
2019-04-09T06:13:09Z
2019-04-09
dc.identifier.none.fl_str_mv 2146-8427
http://hdl.handle.net/10725/10372
Barbari, A. G., Masri, M. A., Stephan, A. G., Mourad, N., El-Ghoul, B., Kamel, G. S., ... & Karam, A. S. (2005). Cyclosporine lymphocyte maximum level: a new alternative for cyclosporine monitoring in kidney transplantation. Exp Clin Transplant, 3(1), 293-300.
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://www.ectrx.org/forms/ectrxcontentshow.php?year=2005&volume=3&issue=1&supplement=0&makale_no=0&spage_number=293&content_type=FULL%20TEXT
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Experimental and clinical transplantation
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Cyclosporine lymphocyte maximum level
a new alternative for cyclosporine monitoring in kidney transplantation
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Objectives: To determine the relationship between clinical outcome, lymphocyte count (LC), and cyclosporine (CsA) lymphocyte maximum level (LTmL) in kidney transplant recipients. Materials and Methods: CsA LTmL was determined in patients with biopsy-proven graft dysfunction and in patients with normal graft function. Clinical outcome was compared according to CsA LTmL, dosage, blood trough (C0) and maximum (Cmax) levels, hematocrit level, and LC. Results: Rejecting patients had significantly lower LTmL than did those with normal graft function (27 ± 11 pg/Lc vs 71 ± 79 pg/Lc; P < 0.01) and similar LTmL to those with nephrotoxicity (27 ± 8 pg/Lc). Patients with normal graft function exhibited significantly lower LC (0.001292 ± 696 x 109/L) and serum creatinine levels (88.4 ± 35 µmol/L) when compared with rejecting patients (0.001717 ± 364 x 109/L, 132.6 ± 8.8 µmol/L) and those with nephrotoxicity (0.001884 ± 582 x 109/L, 123.7 ± 8.8 µmol/L) (P < 0.03, P < 0.001). No significant difference was observed among the 3 groups with regard to CsA dosage, C0, Cmax, mycophenolate mofetil (MMF) dosage, and mycophenolic acid (MPA) plasma levels. CsA LTmL closely correlated in an exponential (R2 = 0.98) and linear (R2 = 0.35) fashion with LC and hematocrit level, respectively. Conversely, CsA Cmax failed to correlate with C0 and these 2 latter parameters. Weak correlations were observed between CsA Cmax and its corresponding LTmL. Conclusions: CsA LTmL appears to correlate better than CsA Cmax with rejection-free outcome and LC. An increase in hematocrit appears to have an adverse effect on CsA lymphocyte binding. CsA LTmL may offer a new alternative for CsA monitoring in kidney transplantation.
eu_rights_str_mv openAccess
format article
id LAURepo_49254a1e15fd4e8eac02af1ebb60ac56
identifier_str_mv 2146-8427
Barbari, A. G., Masri, M. A., Stephan, A. G., Mourad, N., El-Ghoul, B., Kamel, G. S., ... & Karam, A. S. (2005). Cyclosporine lymphocyte maximum level: a new alternative for cyclosporine monitoring in kidney transplantation. Exp Clin Transplant, 3(1), 293-300.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/10372
publishDate 2005
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Cyclosporine lymphocyte maximum levela new alternative for cyclosporine monitoring in kidney transplantationKilani, Halal E.Karam, Albert S.Masri, Marwan A.Stephan, Antoine G.Mourad, NinaEl Ghoul, BassamObjectives: To determine the relationship between clinical outcome, lymphocyte count (LC), and cyclosporine (CsA) lymphocyte maximum level (LTmL) in kidney transplant recipients. Materials and Methods: CsA LTmL was determined in patients with biopsy-proven graft dysfunction and in patients with normal graft function. Clinical outcome was compared according to CsA LTmL, dosage, blood trough (C0) and maximum (Cmax) levels, hematocrit level, and LC. Results: Rejecting patients had significantly lower LTmL than did those with normal graft function (27 ± 11 pg/Lc vs 71 ± 79 pg/Lc; P < 0.01) and similar LTmL to those with nephrotoxicity (27 ± 8 pg/Lc). Patients with normal graft function exhibited significantly lower LC (0.001292 ± 696 x 109/L) and serum creatinine levels (88.4 ± 35 µmol/L) when compared with rejecting patients (0.001717 ± 364 x 109/L, 132.6 ± 8.8 µmol/L) and those with nephrotoxicity (0.001884 ± 582 x 109/L, 123.7 ± 8.8 µmol/L) (P < 0.03, P < 0.001). No significant difference was observed among the 3 groups with regard to CsA dosage, C0, Cmax, mycophenolate mofetil (MMF) dosage, and mycophenolic acid (MPA) plasma levels. CsA LTmL closely correlated in an exponential (R2 = 0.98) and linear (R2 = 0.35) fashion with LC and hematocrit level, respectively. Conversely, CsA Cmax failed to correlate with C0 and these 2 latter parameters. Weak correlations were observed between CsA Cmax and its corresponding LTmL. Conclusions: CsA LTmL appears to correlate better than CsA Cmax with rejection-free outcome and LC. An increase in hematocrit appears to have an adverse effect on CsA lymphocyte binding. CsA LTmL may offer a new alternative for CsA monitoring in kidney transplantation.PublishedN/A2019-04-09T06:13:09Z2019-04-09T06:13:09Z20052019-04-09Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article2146-8427http://hdl.handle.net/10725/10372Barbari, A. G., Masri, M. A., Stephan, A. G., Mourad, N., El-Ghoul, B., Kamel, G. S., ... & Karam, A. S. (2005). Cyclosporine lymphocyte maximum level: a new alternative for cyclosporine monitoring in kidney transplantation. Exp Clin Transplant, 3(1), 293-300.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttp://www.ectrx.org/forms/ectrxcontentshow.php?year=2005&volume=3&issue=1&supplement=0&makale_no=0&spage_number=293&content_type=FULL%20TEXTenExperimental and clinical transplantationinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/103722021-03-19T10:45:18Z
spellingShingle Cyclosporine lymphocyte maximum level
Kilani, Halal E.
status_str publishedVersion
title Cyclosporine lymphocyte maximum level
title_full Cyclosporine lymphocyte maximum level
title_fullStr Cyclosporine lymphocyte maximum level
title_full_unstemmed Cyclosporine lymphocyte maximum level
title_short Cyclosporine lymphocyte maximum level
title_sort Cyclosporine lymphocyte maximum level
url http://hdl.handle.net/10725/10372
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://www.ectrx.org/forms/ectrxcontentshow.php?year=2005&volume=3&issue=1&supplement=0&makale_no=0&spage_number=293&content_type=FULL%20TEXT